Probiotic treatment for ischemic cerebrovascular disease
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This trial tests a new approach for people with ischemic cerebrovascular disease (a condition where blood flow to the brain is blocked). It aims to see if a special treatment involving Lactobacillus acidophilus can improve recovery and prevent future problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 35 and 65 years old
- Be of Han nationality
- Have been diagnosed with ischemic cerebrovascular disease with mild to moderate symptoms
- Be able to communicate normally and complete thinking tests on your own
- Not have had any surgery before
- Not have a history of stroke, dementia, mental illness, or cancer in your family
- Not be allergic to Lactobacillus acidophilus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a treatment called LA (a type of medication) can improve recovery and thinking after surgery for a blocked artery in the neck that can cause strokes. It may help people who have had mild to moderate stroke symptoms.
This trial tests whether tiny particles from stem cells can help people recover thinking and memory after a recent stroke. Doctors will check if the treatment is safe and if it boosts brain function.
This trial tests whether taking a probiotic (a beneficial bacteria supplement) soon after a moderate-to-severe ischemic stroke can help improve recovery. It is for older adults who can start treatment within 3 days of their stroke.
This trial tests a new probiotic (Lactococcus lactis CKDB001) to see if it can slow memory loss in people with early Alzheimer's. It’s a 12-week study that requires a positive amyloid PET scan and allows mild to moderate symptoms.
This trial tests whether a daily supplement of friendly bacteria and prebiotics (called a synbiotic) can help people with Alzheimer's. It looks at how the supplement affects thinking, behavior, and daily life over time.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
Hear when a new Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.